Lookian, P.P.; Zhao, D.; Medina, R.; Wang, H.; Zenka, J.; Gilbert, M.R.; Pacak, K.; Zhuang, Z.
Mannan-BAM, TLR Ligands, Anti-CD40 Antibody (MBTA) Vaccine Immunotherapy: A Review of Current Evidence and Applications in Glioblastoma. Int. J. Mol. Sci. 2021, 22, 3455.
https://doi.org/10.3390/ijms22073455
AMA Style
Lookian PP, Zhao D, Medina R, Wang H, Zenka J, Gilbert MR, Pacak K, Zhuang Z.
Mannan-BAM, TLR Ligands, Anti-CD40 Antibody (MBTA) Vaccine Immunotherapy: A Review of Current Evidence and Applications in Glioblastoma. International Journal of Molecular Sciences. 2021; 22(7):3455.
https://doi.org/10.3390/ijms22073455
Chicago/Turabian Style
Lookian, Pashayar P., David Zhao, Rogelio Medina, Herui Wang, Jan Zenka, Mark R. Gilbert, Karel Pacak, and Zhengping Zhuang.
2021. "Mannan-BAM, TLR Ligands, Anti-CD40 Antibody (MBTA) Vaccine Immunotherapy: A Review of Current Evidence and Applications in Glioblastoma" International Journal of Molecular Sciences 22, no. 7: 3455.
https://doi.org/10.3390/ijms22073455
APA Style
Lookian, P. P., Zhao, D., Medina, R., Wang, H., Zenka, J., Gilbert, M. R., Pacak, K., & Zhuang, Z.
(2021). Mannan-BAM, TLR Ligands, Anti-CD40 Antibody (MBTA) Vaccine Immunotherapy: A Review of Current Evidence and Applications in Glioblastoma. International Journal of Molecular Sciences, 22(7), 3455.
https://doi.org/10.3390/ijms22073455